The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: cephalexin     Quarter: 2016Q3

Total Records: 172     Number of Pages: 9

DRUGNAME PT EventCount
CEPHALEXIN. Joint swelling 2
CEPHALEXIN. Nasopharyngitis 2
CEPHALEXIN. Neuropathy peripheral 2
CEPHALEXIN. Renal tubular necrosis 2
CEPHALEXIN. Sensitivity of teeth 2
CEPHALEXIN. Squamous cell carcinoma 2
CEPHALEXIN. Weight increased 2
CEPHALEXIN - GENERIC FOR KEFLEX AUROBINDO Clostridium difficile colitis 1
CEPHALEXIN - GENERIC FOR KEFLEX AUROBINDO Decreased appetite 1
CEPHALEXIN - GENERIC FOR KEFLEX AUROBINDO Dehydration 1
CEPHALEXIN - GENERIC FOR KEFLEX AUROBINDO Drug ineffective 1
CEPHALEXIN - GENERIC FOR KEFLEX AUROBINDO Prescribed overdose 1
CEPHALEXIN - GENERIC FOR KEFLEX AUROBINDO Weight decreased 1
CEPHALEXIN /00145501/ Drug hypersensitivity 1
CEPHALEXIN 500 CAPSULES Blood glucose increased 1
CEPHALEXIN 500 CAPSULES Feeling abnormal 1
CEPHALEXIN 500 CAPSULES Impaired quality of life 1
CEPHALEXIN 500 MG AUR Abdominal distension 1
CEPHALEXIN 500 MG AUR Constipation 1
CEPHALEXIN 500 MG AUR Flatulence 1

Total Records: 172     Number of Pages: 9